The impacts of AIDS movements on the policy responses to HIV/AIDS in Brazil and South Africa: A comparative analysis

Global Public Health

Volumn 7, Issue 10, 2012, Pages 1031-1044

  Nunn, Amy ^a   Dickman, Samuel ^b   Nattrass, Nicoli ^c   Cornwall, Alexandra ^b   Gruskin, Sofia ^d  

^a BROWN UNIVERSITY   (United States)

^b MIRIAM HOSPITAL   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

AIDS; AIDS movements; Brazil; civil society; health policy; HIV; South Africa

Indexed keywords

GENERIC DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BRAZIL; COMPARATIVE STUDY; EPIDEMIC; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; SOUTH AFRICA;

BRAZIL; DRUG INDUSTRY; FEMALE; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; LEADERSHIP; MALE; PATIENT ADVOCACY; SOUTH AFRICA;

EID: 84870887566     PISSN: 17441692     EISSN: 17441706     Source Type: Journal    
DOI: 10.1080/17441692.2012.736681     Document Type: Article

References (53)

1. ASSA, 2010. ASSA AIDS committee models [online]. AIDS Actuarial Society of South Africa. Available from: http://aids.actuarialsociety.org.za/ [Accessed 15 June 2011].
2. Berkman, A., Garcia, J., Munoz-Laboy, M., Paiva, V. and Parker, R. 2005. A critical analysis of the Brazilian response to HIV/AIDS: lessons learned for controlling and mitigating the epidemic in developing countries. American journal of public health, 95: 1162-1172. doi:10.2105/AJPH.2004.054593
3. Bermudez, J. 1995. Indústria Farmacêutica, Estado e Sociedade [The pharmaceutical industry, the state, and society], São Paulo: HUCITEC Limitada.
4. Braga, C.P. 1996. "Trade-related intellectual property issues: the Uruguay Round Agreement and its implications for developing countries". In The Uruguay Round and the developing countries, Edited by: Martin, W. and Winters, L.A. 341-379. Cambridge: Cambridge University Press.
5. Braga, C. and Carsten, F. 1998. Reforming intellectual property rights regimes: challenges for developing countries. Journal of international economic law, 1: 537-554. doi:10.1093/jiel/1.4.537
6. Chequer, P., November 25, 2005. Interview by Amy Nunn, digital recording. National STD and AIDS Program Brasília Brazil.
7. Chigwedere, P., Seage, G.R., Gruskin, S., Lee, T.H. and Essex, M. 2008. Estimating the lost benefits of antiretroviral drug use in South Africa. Journal of acquired immune deficiency syndrome, 49: 4 doi:10.1097/QAI.0b013e31818a6cd5
8. Coetzee, D., Hildebrand, K., Boulle, A., Maartens, G., Louis, F., Labatala, V., Reuter, H., Ntwana, N. and Goemaere, E. 2004. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS, 18: 887-895. doi:10.1097/00002030-200404090-00006
9. Cohen, J. 2006. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after. Science, 313: 484-487.
10. Cohen, M.S., Chen, Y.Q., McCauley, M., Gamble, T., Hosseinipour, M.C., Kumarasamy, N., Hakim, J.G., Kumwenda, J., Grinsztejn, B., Pilotto, J.H., Godbole, S.V., Mehendale, S., Chariyalertsak, S., Santos, B.R., Mayer, K.H., Hoffman, I.F., Eshleman, S.H., Piwowar-Manning, E., Wang, L., Makhema, J., Mills, L.A., de Bruyn, G., Sanne, I., Eron, J., Gallant, J., Havlir, D., Swindells, S., Ribaudo, H., Elharrar, V., Burns, D., Taha, T.E., Nielsen-Saines, K., Celentano, D., Essex, M. and Fleming, T.R. 2011. Prevention of HIV-1 infection with early antiretroviral therapy. New England journal of medicine, 365: 493-505. doi:10.1056/NEJMoa1105243
11. Das, M., Chu, P.L., Santos, G.M., Scheer, S., Vittinghoff, E., McFarland, W. and Colfax, G.N. 2010. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS one, 5: e11068 doi:10.1371/journal.pone.0011068
12. Del Bianco, R., December 7, 2005. Interview with Amy Nunn, digital recording. Clinic of Rosanna del Bianco, São Paulo.
13. Donnell, D., Baeten, J.M., Kiarie, J., Thomas, K.K., Stevens, W., Cohen, C.R., McIntyre, J., Lingappa, J.R. and Celum, C. 2010. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet, 375: 2092-2098. doi:10.1016/S0140-6736(10)60705-2
14. Dourado, I., Veras, M.A., Barreira, D. and De Brito, A.M. 2006. Tendências da Epidemia de AIDS no Brasil Após a Terapia Anti-retroviral. Revista de Saúde Pública, 40: 91-97.
15. Galvão, J. 1997. "As Respostas das Organizações Não-governmentais [The responses of NGOs]". In Políticas, instituições e AIDS [Politics, Institutions and AIDS], Edited by: Parker, R. Rio de Janeiro: ABIA.
16. Galvão, J. 2000. AIDS no Brasil: a agenda de construção de uma epidemia [AIDS in Brazil], Rio de Janeiro: ABIA.
17. Galvão, J. 2002. Access to antiretroviral drugs in Brazil. Lancet, 360: 1862-1865. doi:10.1016/S0140-6736(02)11775-2
18. Galvão, J. 2005. Brazil and access to HIV/AIDS drugs: a question of human rights and public health. American journal of public health, 95: 1110-1116. doi:10.2105/AJPH.2004.044313
19. Gauri, V. and Lieberman, E. 2006. Boundary institutions and HIV/AIDS policy in Brazil and South Africa. Studies in comparative international development, 41: 47-73. doi:10.1007/BF02686236
20. Geffen, N. 2010. Debunking delusion: the inside story of the Treatment Action Campaign, Cape Town: Jacana.
21. Grangeiro, A., Escuder, M.M. and Castilho, E.A. 2010a. The AIDS epidemic in Brazil and differences according to geographic region and health services supply. Cadernos da Saude Publica, 26: 2355-2367. doi:10.1590/S0102-311X2010001200014
22. Grangeiro, A., Escuder, M.M. and Castilho, E.A. 2010b. Magnitude and trend of the AIDS epidemic in Brazilian cities, from 2002 to 2006. Revista Saude Publica, 44: 430-440. doi:10.1590/S0034-89102010005000013
23. Grundlingh, L., 2001. A critical historical analysis of government responses to HIV/AIDS in South Africa as reported in the media, 1983-94. In: International AIDS in context. Johannesburg: University of the Witwatersrand.
24. Guimarães, M. 2000. Temporal trends in AIDS-associated opportunistic infections in Brazil, 1980-1999. Cadernos da Saúde Pública, 16: 21-36.
25. Jornal do Brasil, 1988. Brasil bate França e é segundo do mundo em AIDS [Brazil rivals France and is second in the world in AIDS cases]. São Paulo: Jornal do Brasil.
26. Kalichman, S. 2009. Denying AIDS: conspiracy theories, pseudoscience, and human tragedy, New York: Springer Science + Business Media, LLC.
27. Kaplan, W. and Laing, R., 2005. Local production of pharmaceuticals: industrial policy and access to medicines [online]. Washington, DC, World Bank. Available from: http://siteresources.worldbank.org/HEALTHNUTRITIONANDPOPULATION/Resources/281627-1095698140167/KaplanLocalProductionFinal.pdf [Accessed 15 October 2011].
28. Marins, J.R., Jamal, L., Chen, S., Barros, M., Hudes, E., Barbosa, A., Chequer, P., Teixeira, P. and Hearst, N. 2003. Dramatic improvement in survival among adult Brazilian AIDS patients. AIDS, 17: 1675-1682. doi:10.1097/00002030-200307250-00012
29. Motsoaledi, A., 2010. Outline of the national HIV counselling and testing (HCT) campaign. South African Department of Health. Available from: http://www.westerncape.gov.za/other/2010/6/hct_campaign_strategy_2_3_10_final.pdf [Accessed 10 October 2012].
30. NAP, 2005. Plano Estratégico 2005-Programa Nacional de DST e AIDS [2005 Strategic Plan: National STD and AIDS Program of Brazil]. Brasília: Programa Nacional de DST/AIDS.
31. Nattrass, N. 2003. The moral economy of AIDS in South Africa, Cambridge: Cambridge University Press.
32. Nattrass, N. 2006. South Africa's 'rollout' of antiretroviral treatment: a critical assessment. Journal of acquired immune deficiency syndrome, 43: 618-623.
33. Nattrass, N. 2007. Mortal combat: AIDS denialism and the struggle for antiretrovirals in South Africa, Scottsville: University of KwaZulu-Natal Press.
34. Nattrass, N. 2008. AIDS and the scientific governance of medicine in post-apartheid South Africa. African affairs, 107: 157-176. doi:10.1093/afraf/adm087
35. Nattrass, N. and Geffen, N. 2005. The impact of reduced drug prices on the cost-effectiveness of HAART in South Africa. African journal of AIDS research, 4: 65-67. doi:10.2989/16085900509490343
36. Nunn, A. 2009. The politics and history of AIDS treatment in Brazil, New York: Springer.
37. Nunn, A., da Fonseca, E., Bastos, F. and Gruskin, S. 2009a. AIDS treatment in Brazil: impacts and challenges. Health affairs, 28(4): 1103-1113. doi:10.1377/hlthaff.28.4.1103
38. Nunn, A., Fonseca, E.D. and Gruskin, S. 2009b. Changing global essential medicines norms to improve access to AIDS treatment: lessons from Brazil. Global public health, 4: 131-149. doi:10.1080/17441690802684067
39. Nunn, A., Fonseca, E.M., Bastos, F., Gruskin, S. and Salomon, J.A. 2007. Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment. PLoS Medicine, 4: e305 doi:10.1371/journal.pmed.0040305
40. Okie, S. 2006. Fighting HIV-lessons from Brazil. New England journal of medicine, 354: 1977-1981. doi:10.1056/NEJMp068069
41. Parker, R., 1997. Politicas, instituições e AIDS: enfrentando a epidemia no Brasil [Politics, institutions and AIDS: responding to the epidemic in Brazil]. Rio de Janeiro: Jorge Zahar Editora/Associação Brasileira Interdisciplinar de AIDS.
42. Parkhurst, J.O. and Lush, L. 2004. The political environment of HIV: lessons from a comparison of Uganda and South Africa. Social science and medicine, 59(2004): 1913-1924.
43. Pfizer, 2000. Diflucan partnership factsheet, direct relief international [online]. Available from: http://www.directrelief.org/DiflucanPartnership/EN/DiflucanProgramOverview.aspx [Accessed 15 October 2012].
44. Quinn, T.C., Wawer, M.J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., Meehan, M.O., Lutalo, T. and Gray, R.H. 2000. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. New England journal of medicine, 342: 921-929. doi:10.1056/NEJM200003303421303
45. Scheffer, M., Salazar, A. and Grou, K. 2005. O Remédio via Justiça [Drugs through the courts], Brasília: Programa Nacional de DST/AIDS.
46. Schneider, H. and Gilson, L. 1998. Making effective use of foreign aid to the South African health sector, Johannesburg: Centre for Health Policy, University of Witwatersrand and London School of Hygiene and Tropical Medicine.
47. UNAIDS, 2010a. UNAIDS report on the global aids epidemic 2010 [online]. Geneva, UNAIDS. Available from: http://www.unaids.org/globalreport/Global_report.htm [Accessed 15 December 2011].
48. UNAIDS, 2010b. UNAIDS welcomes South Africa's new US$1.1 billion investment on AIDS for 2010 [online]. Geneva, UNAIDS. Available from: www.unaids.org [Accessed 15 December 2011].
49. UNGASS, 2008. Targets and commitments made by the member-states at the United Nations General Assembly Special Session on HIV/AIDS UNGASS-HIV/AIDS: Brazilian Response 2005/2007 Country Progress Report. New York: UNGASS.
50. Vallancourt, D. 2004. Project performance assessment report: Brazil First and Second AIDS and STD Control Projects, Washington, DC: World Bank.
51. World Bank, 1993. Brazil AIDS and STD control project: World Bank staff appraisal report. Washington, DC: World Bank.
52. World Bank, 2003. Third STD and AIDS control project: a loan agreement between Federative Republic of Brazil and the World Bank. Washington, DC: World Bank.
53. Zizola, F., 2009. Doctors Without Borders. Stagnation of HIV/AIDS funding [online]. Doctors Without Borders. Available from: http://www.msf.org.uk/suboptimal_treatment_20090720.news [Accessed 24 March 2011].